Untreated head and neck cancer: Natural history and associated factors
- PMID: 32914515
- PMCID: PMC8970342
- DOI: 10.1002/hed.26460
Untreated head and neck cancer: Natural history and associated factors
Abstract
Background: This study aims to provide modern estimates of survival for untreated head and neck cancer (HNC) and to identify patient- and tumor-specific factors associated with not receiving definitive treatment.
Methods: Adults with mucosal HNC were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Median overall survival of untreated patients was calculated and stratified by site and stage. Cause-specific survival and factors associated with no treatment were investigated with advanced statistics.
Results: The study cohort included 6477 patients who received no treatment. Overall, untreated patients had a median survival of 12 months, with significant variability by site and stage. Multivariable analysis identified advanced age, black race, unmarried status, and lack of private insurance as associated with no treatment.
Conclusions: Survival of HNC without treatment is dismal, yet substantial variation exists by tumor site and stage. Higher rates of no treatment among the poor and racial minorities are potentially driven by disparities in care availability and provision.
Keywords: epidemiology; head and neck cancer; natural history; socioeconomic factors; treatment disparity.
© 2020 Wiley Periodicals LLC.
Figures



Similar articles
-
Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.Oncologist. 2021 Jul;26(7):579-587. doi: 10.1002/onco.13763. Epub 2021 Apr 15. Oncologist. 2021. PMID: 33783061 Free PMC article.
-
Insurance status, stage of presentation, and survival among female patients with head and neck cancer.Laryngoscope. 2020 Feb;130(2):385-391. doi: 10.1002/lary.27929. Epub 2019 Mar 22. Laryngoscope. 2020. PMID: 30900256
-
A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.Otolaryngol Head Neck Surg. 2019 Feb;160(2):284-294. doi: 10.1177/0194599818792205. Epub 2018 Aug 21. Otolaryngol Head Neck Surg. 2019. PMID: 30129822
-
Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16. Cancer. 2019. PMID: 30444527
-
Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis.Cancer Causes Control. 2019 Jul;30(7):721-732. doi: 10.1007/s10552-019-01185-z. Epub 2019 May 22. Cancer Causes Control. 2019. PMID: 31119434 Free PMC article.
Cited by
-
Outcomes and Prognostic Factors in Patients With Untreated Head and Neck Squamous Cell Carcinoma.Cureus. 2025 Jan 8;17(1):e77141. doi: 10.7759/cureus.77141. eCollection 2025 Jan. Cureus. 2025. PMID: 39791020 Free PMC article.
-
Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review).Oncol Lett. 2023 Jul 17;26(3):372. doi: 10.3892/ol.2023.13958. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37965160 Free PMC article. Review.
-
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC.BMC Mol Cell Biol. 2024 Feb 10;25(1):4. doi: 10.1186/s12860-024-00500-0. BMC Mol Cell Biol. 2024. PMID: 38336617 Free PMC article.
-
Acetylsalicylic Acid and Head and Neck Cancer: Risk, Five-Year Survival, and Recurrence in over 11,000,000 Patients-A Retrospective Case-Control Study.Cancers (Basel). 2025 Jun 20;17(13):2065. doi: 10.3390/cancers17132065. Cancers (Basel). 2025. PMID: 40647366 Free PMC article.
-
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.Cancers (Basel). 2023 Nov 2;15(21):5257. doi: 10.3390/cancers15215257. Cancers (Basel). 2023. PMID: 37958430 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians. 2019;69:7–34. - PubMed
-
- L’Esperance HE, Kallogjeri D, Yousaf S, Piccirillo JF, Rich JT. Prediction of mortality and morbidity in head and neck cancer patients 80 years of age and older undergoing surgery. The Laryngoscope. 2018;128:871–7. - PubMed
-
- Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, et al. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head & neck. 2017;39:2151–8. - PubMed
-
- Choi HG, Park B, Ahn S-H. Untreated head and neck cancer in Korea: a national cohort study. European Archives of Oto-Rhino-Laryngology. 2017;274:1643–50. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical